Solid Biosciences Inc (NASDAQ: SLDB) started the day on Wednesday, with a price decrease of -7.56% at $5.38, before settling in for the price of $5.82 at the close. Taking a more long-term approach, SLDB posted a 52-week range of $2.41-$7.37.
It was noted that the giant of the Healthcare sector posted annual sales growth of 41.25% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 41.25%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.67%. This publicly-traded company’s shares outstanding now amounts to $77.88 million, simultaneously with a float of $58.88 million. The organization now has a market capitalization sitting at $419.16 million. At the time of writing, stock’s 50-day Moving Average stood at $5.33, while the 200-day Moving Average is $4.91.
Solid Biosciences Inc (SLDB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Solid Biosciences Inc’s current insider ownership accounts for 24.42%, in contrast to 82.76% institutional ownership. According to the most recent insider trade that took place on Dec 03 ’25, this organization’s Chief Operating Officer sold 4,932 shares at the rate of 5.11, making the entire transaction reach 25,203 in total value, affecting insider ownership by 32,908. Preceding that transaction, on Dec 03 ’25, Company’s President and CEO sold 10,808 for 5.11, making the whole transaction’s value amount to 55,229. This particular insider is now the holder of 81,388 in total.
Solid Biosciences Inc (SLDB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
Solid Biosciences Inc’s EPS increase for this current 12-month fiscal period is 31.67% and is forecasted to reach -2.04 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.41% through the next 5 years, which can be compared against the 41.25% growth it accomplished over the previous five years trading on the market.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Let’s observe the current performance indicators for Solid Biosciences Inc (SLDB). It’s Quick Ratio in the last reported quarter now stands at 6.74. In the same vein, SLDB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.49, a figure that is expected to reach -0.50 in the next quarter, and analysts are predicting that it will be -2.04 at the market close of one year from today.
Technical Analysis of Solid Biosciences Inc (SLDB)
If we take a close look at the recent performances of Solid Biosciences Inc (NASDAQ: SLDB), its last 5-days Average volume was 0.82 million that shows plunge from its year to date volume of 1.63 million. During the previous 9 days, stock’s Stochastic %D was recorded 41.38% While, its Average True Range was 45.66.
Raw Stochastic average of Solid Biosciences Inc (SLDB) in the period of the previous 100 days is set at 44.41%, which indicates a major rise in contrast to 37.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.36 that was lower than 0.40 volatility it exhibited in the past 100-days period.
